
0.7325 Delayed Data As of Nov 30 | ![]() Today’s Change | 0.71 Today|||52-Week Range 2.52 | -54.22% Year-to-Date |
Previous close | 0.75 |
Today’s open | 0.78 |
Day’s range | 0.75 - 0.78 |
Volume | 1,678 |
Average volume (3 months) | 12,346 |
Market cap | $23.2M |
Earnings growth (last year) | +32.91% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
CYCCCyclacel Pharmaceuti... | -0.03 | -10.03% |
NBSENeuBase Therapeutics... | -0.08 | -7.75% |
---- | ||
CYCCPCyclacel Pharmaceuti... | +0.05 | +0.55% |
Last reporting date | April 7, 2022 |
EPS forecast (this quarter) | -$0.20 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$3.6M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |